Get startedLog in
    Picture of BLS Pharmaceuticals logo

    BXNDA — BLS Pharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    All News

    Brief: Bioxyne Signs Joint Venture With Canxchange

    Picture of BLS Pharmaceuticals logoBLS Pharmaceuticals
    15/08/2023 02:21
    Aug 15 (Reuters) - Bioxyne Ltd  BXN.AX :
    * BIOXYNE SIGNS JOINT VENTURE WITH CANXCHANGE
    * JOINT VENTURE TO LAUNCH AI-POWERED B2B PLATFORM IN
AUSTRALIA
HIGHLIGHTS
    * PLATFORM, EXPECTED TO GO LIVE IN AUSTRALIA IN Q4 2023,
WILL
TARGET AUSTRALIA'S FAST GROWING MEDICINAL CANNABIS

Source text for Eikon:  ID:nASXbDhWwk 
Further company coverage:  BXN.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on BLS Pharmaceuticals

    See all news